| Politician | Action | Description | Traded |
|---|---|---|---|
| Buy | Edwards Lifesciences Corpora | Mar 27, 2026 | |
| Buy | EDWARDS LIFESCIENCES CORPORA | Jan 15, 2026 | |
| Sell | Edwards Lifesciences Corpora | Nov 19, 2025 | |
| Sell | Edwards Lifesciences Corpora | May 12, 2025 | |
| Sell | Edwards Lifesciences Corpora | Apr 21, 2025 | |
| Buy | Edwards Lifesciences Corpora | Apr 8, 2025 | |
| Buy | Edwards Lifesciences Corpora | Apr 7, 2025 | |
| Buy | EDWARDS LIFESCIENCES CORPORA | Mar 12, 2025 | |
| Buy | Edwards Lifesciences Corpora | Mar 3, 2025 | |
| Sell | EATON CORP PLC CMN | Feb 5, 2025 |
This page tracks congressional stock trading activity in Edwards Lifesciences Corporation (EW) in the Healthcare sector. Disclosed Capitol has indexed 115 disclosed congressional trades involving EW. Every trade is sourced from official STOCK Act financial disclosure filings — the same primary records the Senate and House are required to publish. The full trade list with politician names, transaction types, amount ranges, and disclosure dates is below, alongside cross-references to any related lobbying activity, federal contracts, and committee assignments.
As of July 2026 — Disclosed Capitol has tracked 115 disclosed congressional trades in Edwards Lifesciences Corporation (EW) — 54:42 sell-heavy ratio — led by Ro Khanna (D).
| Date | Politician | Party | Action | Amount |
|---|---|---|---|---|
| Mar 27, 2026 | Alan Armstrong | R | Buy | $1,001 - $15,000 |
| Jan 15, 2026 | Ro Khanna | D | Purchase | $1,001 - $15,000 |
| Nov 19, 2025 | Josh Gottheimer | D | Sale | $1,001 - $15,000 |
| May 12, 2025 | Jefferson Shreve | R | Sale | $50,001 - $100,000 |
| Apr 21, 2025 | Bruce Westerman | R | Sale | $1,001 - $15,000 |
| Apr 8, 2025 | Rob Bresnahan | R | Buy | $1,001 - $15,000 |
| Apr 7, 2025 | Jefferson Shreve | R | Buy | $15,001 - $50,000 |
| Mar 12, 2025 | Ro Khanna | D | Purchase | $1,001 - $15,000 |
| Mar 3, 2025 | Bruce Westerman | R | Buy | $1,001 - $15,000 |
| Feb 5, 2025 | Ro Khanna | D | Sale | $50,001 - $100,000 |
Across the 115 disclosed congressional trades in Edwards Lifesciences Corporation (EW), members of Congress have reported 42 buys and 54 sells. The average 30-day alpha vs. the S&P 500 is -1.13%.
As of June 2026, Edwards Lifesciences Corporation has 859 federal contract award records on file from USAspending.gov — most recently $136K from the Department of Veterans Affairs on 2026-06-25.
| Award date | Agency | Amount |
|---|---|---|
| 2026-06-25 | Department of Veterans Affairs | $136K |
| 2026-06-23 | Department of Veterans Affairs | $65K |
| 2026-06-23 | Department of Veterans Affairs | $68K |
| 2026-06-23 | Department of Veterans Affairs | $102K |
| 2026-06-18 | Department of Veterans Affairs | $65K |
| 2026-06-10 | Department of Veterans Affairs | $102K |
| 2026-06-08 | Department of Veterans Affairs | $136K |
| 2026-06-05 | Department of Veterans Affairs | $102K |
| 2026-06-03 | Department of Veterans Affairs | $68K |
| 2026-06-01 | Department of Veterans Affairs | $72K |
Negative amounts are contract de-obligations. Browse and filter every award on the government contracts page.
For fiscal year 2025, Edwards Lifesciences Corporation reported revenue of $6.07B and net income of $1.07B, per SEC filings.
Most recent reported quarter: Q2 FY2026 — revenue $1.74B, net income $241.9M.
Figures come from SEC financial statement filings. The full annual and quarterly statement history is in the Financials tab above.